Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

Fingerhut out as Cleveland Clinic Innovations ED

The executive director of Cleveland Clinic Innovations is out after the FBI told the hospital system that he made financial transactions that violated internal policies.  

Diabetic registries for MU results in better care

Practices that use electronic registries for patient reminders are more likely to complete recommended laboratory testing for their patients with type 2 diabetes, according to research published in the Journal of the Medical Informatics Association. 

ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation

ICD-10 Charts (www.icd10charts.com) announced today that after 6 months of development, it has officially launched its newest line of ICD-10 preparation resources, the ICD-10 Charts Training Academy and the new 4 Step ICD-10 Implementation Plan.  

Thumbnail

Gift to Icahn to establish precision wellness center

The Icahn School of Medicine at Mount Sinai has received a $5 million gift that will establish the Harris Center for Precision Wellness. 

Thumbnail

CMS to try value-based home health

The Centers for Medicare & Medicaid Services (CMS) announced a proposal to launch a new model designed to test whether incenties for better care can improve outcomes in the delivery of home health services.

Thumbnail

Cerner, University of Missouri extend relationship for more care innovation

After nearly two decades of collaboration, the University of Missouri (MU) and Cerner announced plans to extend their relationship through 2025. 

ONC considering more options for certification program

The Office of the National Coordinator for Health IT (ONC) is accepting submissions of test procedures, test tools and test data for certification. 

Thumbnail

Aetna to acquire Humana in $37B deal

Health insurer Aetna has agreed to acquire its smaller rival Humana for $37 billion in cash and stock, bringing together two of the biggest U.S. health insurers. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.